Alignment Healthcare Sues CMS After Share of Members in Plans Rated Four Stars or Higher Falls to 25%

Alignment Healthcare sued CMS, alleging unlawful calculation of 2027 Medicare Advantage star ratings, which dropped its 4+ star plans to 25% from 100%. The lawsuit claims CMS violated the Administrative Procedure Act. A TD Cowen analyst estimated potential 2028 revenue loss of over $170 million. CMS has not responded, and the case is pending.

Original reporting
Published Oct 14, 2026, 7:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 9:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alignment Healthcare Sues CMS After Share of Members in Plans Rated Four Stars or Higher Falls to 25% — source image
Decision brief

The 30-second read

Med
01

Why it matters

The legal challenge could alter quality bonus payments for 2028, impacting Alignment's revenue and potentially setting precedent for other insurers.

02

Market read

The lawsuit introduces regulatory risk to the Medicare Advantage sector, with possible revenue impact for Alignment and peers.

03

What to watch

The lawsuit may prompt broader regulatory scrutiny of star rating calculations, affecting all MA providers.

Relevance 7/10Novelty 8/10Timing: today

Background

Alignment Healthcare, a Medicare Advantage insurer, sued CMS over the 2027 star rating calculations after its rating share fell dramatically.

Market effects

Potential pressure on Medicare Advantage insurers as star rating methodology faces legal challenge.

US healthcare sector may see heightened volatility during open enrollment period.

Limited; primarily affects US Medicare Advantage market.

Counterpoint

If CMS adjusts methodology favorably, Alignment could recover lost bonus revenue and rebound.

Key entities

  • Alignment Healthcare

    Medicare Advantage insurer filing lawsuit against CMS.

  • CMS

    Centers for Medicare & Medicaid Services overseeing star ratings.

Related articles

$ALHCMed

Why Alignment Healthcare (ALHC) Stock Is Up Today

Alignment Healthcare (ALHC) shares rose 8.6% after its subsidiary announced a new Medicare Advantage plan in Los Angeles and Orange counties. Analyst Ryan Langston lowered his price target to $12 but maintained a Buy rating, citing inpatient utilization pressure. The stock had fallen 13.4% the previous day due to a downgrade and regulatory concerns.

$HUMMedAI 8/10

Humana Rebounds in Medicare Advantage Star Ratings for 2027

Humana's Medicare Advantage star ratings improved significantly for 2027, with 93% of members in plans rated 4 stars or higher, up from 41% in 2026. This could generate $3B+ in additional revenue in 2028, according to TD Cowen. Alignment Healthcare saw a major decline, potentially losing $170M in revenue. CMS changed its star ratings methodology for 2027.

$ALHCHigh

ALHC Stock Slides As Legal, Cost, And Rating Pressures Mount

Alignment Healthcare Inc. (ALHC) stock fell 14.75% on October 9, 2026, amid concerns over Medicare Advantage reimbursement pressures, legal issues, and cost challenges. The company reported $1.34B in revenue and $36.6M in net income for the latest quarter, but negative cash flow raised concerns. CMS's 2027 Star Ratings and a whistleblower's accounting allegations further pressured the stock, with Barclays cutting its price target to $10.